The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease.
- Published In:
- Journal of Alzheimer's disease : JAD, 45(4), 985-1000 (2015)
- Authors:
- Wright, John W, Harding, Joseph W
- Database ID:
- RPEP-02836
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02836APA
Wright, John W; Harding, Joseph W. (2015). The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease.. Journal of Alzheimer's disease : JAD, 45(4), 985-1000. https://doi.org/10.3233/JAD-142814
MLA
Wright, John W, et al. "The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease.." Journal of Alzheimer's disease : JAD, 2015. https://doi.org/10.3233/JAD-142814
RethinkPeptides
RethinkPeptides Research Database. "The Brain Hepatocyte Growth Factor/c-Met Receptor System: A ..." RPEP-02836. Retrieved from https://rethinkpeptides.com/research/wright-2015-the-brain-hepatocyte-growth
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.